CSIMarket Company Name, Ticker, Industry, else..
 
Bioadaptives Inc   (BDPT)
 

Bioadaptives Inc's Suppliers Performance

BDPT's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
BDPT Costs vs Sales of Suppliers Growth Bioadaptives Inc's cost of sales deteriorated by -65.31 % year on year, relative to one quarter ago cost of sales fell by -46.61 % in Q2.

• More on BDPT Suppliers



Bioadaptives Inc's cost of sales deteriorated by -65.31 % year on year, compare to one quarter ago cost of sales fell by -46.61 % in Q2.

• More on BDPT Suppliers




Bioadaptives Inc's Comment on Supply Chain


The Company sources products from suppliers adhering to strict compliance and sustainable agricultural practices. It conducts research on all-natural supplement formulations and natural ingredients that promote stem cell proliferation. In 2022, the Company launched a product line incorporating cyanobacteria and mushrooms. In April 2024, it acquired the Lungflute™ medical device from the sole US affiliate of the patent holder, choosing not to manufacture medical devices internally due to capital and cost considerations. The Company operates as a research and development nutraceutical firm and utilizes external consultants and labor as needed for its business operations.

Bioadaptives Inc's Comment on Supply Chain


The Company sources products from suppliers adhering to strict compliance and sustainable agricultural practices. It conducts research on all-natural supplement formulations and natural ingredients that promote stem cell proliferation. In 2022, the Company launched a product line incorporating cyanobacteria and mushrooms. In April 2024, it acquired the Lungflute™ medical device from the sole US affiliate of the patent holder, choosing not to manufacture medical devices internally due to capital and cost considerations. The Company operates as a research and development nutraceutical firm and utilizes external consultants and labor as needed for its business operations.







BDPT's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Bioadaptives Inc 0.56 0.03 -1.13 1
SUBTOTAL 0.00 0.00 0.00 -


Sources: Bioadaptives Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Bioadaptives Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.